Overview
Broccoli Sprout Intervention in Qidong, P.R. China
Status:
Completed
Completed
Trial end date:
2012-01-01
2012-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is a 12 week placebo-controlled Phase II broccoli sprout intervention to be conducted in Qidong, P.R. China. One thousand two hundred people from the farming townships will be screened and three hundred eligible individuals will be enrolled in the study. Participants will be randomized into two treatment groups: one will receive a juice beverage containing glucoraphanin- and sulforaphane-rich broccoli sprout extract, pineapple juice, lime juice, and water and the other will receive a placebo beverage containing pineapple juice, lime juice and water. Participants will drink their assigned beverage every evening and provide biweekly urine samples and monthly blood samples. The principal endpoints of this study are pharmacokinetic evaluation of elimination of glucoraphanin/sulforaphane and their metabolites in urine and pharmacodynamic evaluation through measures of urinary levels of exposure biomarkers for dietary and air-borne toxins, which are known to be high in this population.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Johns Hopkins Bloomberg School of Public HealthCollaborators:
Johns Hopkins University
National Institute of Environmental Health Sciences (NIEHS)
Qidong Liver Cancer Institute
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
University of Pittsburgh
Criteria
Inclusion Criteria:- age 21-65 years
- in good general health with no history of chronic illness
- normal liver function tests: alanine aminotransferase (ALT), aspartate
aminotransferase (AST), bilirubin)
- normal renal function tests (creatinine, blood urea nitrogen, urinalysis)
- serum alpha-fetoprotein negative
Exclusion Criteria:
- personal history of cancer except for non-melanoma skin cancer
- use of prescribed medications
- hepatomegaly by clinical exam
- for women, a positive pregnancy test